CoChat

Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy

Open access
Agrawal, Shivi, Joshi, Malav, Christoforidis, John B. · 2013 · Mediators of Inflammation

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Vascular endothelial growth factor (VEGF) is a potent promoter of angiogenesis involved in a wide variety of physiologic processes. Intravitreal injections targeting VEGF have transformed the treatment of neovascular retinal diseases. Currently, there are four anti-VEGF agents in use: bevacizumab, ranibizumab, pegaptanib, and aflibercept. The success and frequency of anti-VEGF therapy have made the ocular safety profile of these agents of vital importance. This paper focuses on sterile endophthalmitis. In this paper, we compare the incidences of posttreatment sterile endophthalmitis among the four agents, review the mechanism of actions, and discuss the most prevalent hypotheses leading to sterile endophthalmitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2013/943409

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. 2012, Ophthalmic Surgery Lasers Imaging, 43, e47
  2. 10.3928/15428877-20110603-04 · DOI · Paper page
  3. 2013, Ophthalmology, 120, 1100.5
  4. 1997, Journal of Interferon and Cytokine Research, 17, S15
  5. 1987, Laboratory Investigation, 56, 583

Cited by

See all 87

Metadata

Authors
Agrawal, S., Joshi, M., & Christoforidis, J. B.
Affiliations
Banner - University Medical Center Tucson (US)
Corresponding author
Christoforidis, John B.
Venue
Mediators of Inflammation
Publisher
Wiley
Published
2013
Volume
2013
Pages
1-6
ISSN
  • 0962-9351 (ISSN-L)
  • 1466-1861
OpenAlex
W2022562553
Cited by
83
References
55
Citations by year
2026: 3 · 2025: 6 · 2024: 11 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 8 · 2014: 2
FWCI
0.99
Type
journal article
Language
en
Open access
Locations
  • Mediators of Inflammation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
vitreous inflammation, sterile endophthalmitis, anti-VEGF therapy, intravitreal injection, bevacizumab, ranibizumab, pegaptanib, aflibercept, vascular endothelial growth factor, eye safety, pathogenesis
MeSH terms
Bevacizumab, Ranibizumab, Humans, Infant, Newborn, Inflammation, Endophthalmitis, Recombinant Fusion Proteins, Retinal Diseases, Risk, Vitreous Body, Angiogenesis Inhibitors, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor A, Aptamers, Nucleotide, Intravitreal Injections, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.